1. Home
  2. TPH vs IMVT Comparison

TPH vs IMVT Comparison

Compare TPH & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPH
  • IMVT
  • Stock Information
  • Founded
  • TPH 2009
  • IMVT 2018
  • Country
  • TPH United States
  • IMVT United States
  • Employees
  • TPH N/A
  • IMVT N/A
  • Industry
  • TPH Homebuilding
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TPH Consumer Discretionary
  • IMVT Health Care
  • Exchange
  • TPH Nasdaq
  • IMVT Nasdaq
  • Market Cap
  • TPH 2.9B
  • IMVT 2.7B
  • IPO Year
  • TPH N/A
  • IMVT N/A
  • Fundamental
  • Price
  • TPH N/A
  • IMVT $16.08
  • Analyst Decision
  • TPH Buy
  • IMVT Buy
  • Analyst Count
  • TPH 6
  • IMVT 10
  • Target Price
  • TPH $41.20
  • IMVT $33.38
  • AVG Volume (30 Days)
  • TPH 977.9K
  • IMVT 1.7M
  • Earning Date
  • TPH 10-23-2025
  • IMVT 11-06-2025
  • Dividend Yield
  • TPH N/A
  • IMVT N/A
  • EPS Growth
  • TPH N/A
  • IMVT N/A
  • EPS
  • TPH 3.96
  • IMVT N/A
  • Revenue
  • TPH $4,041,885,000.00
  • IMVT N/A
  • Revenue This Year
  • TPH N/A
  • IMVT N/A
  • Revenue Next Year
  • TPH $1.33
  • IMVT N/A
  • P/E Ratio
  • TPH $8.17
  • IMVT N/A
  • Revenue Growth
  • TPH N/A
  • IMVT N/A
  • 52 Week Low
  • TPH $27.90
  • IMVT $12.72
  • 52 Week High
  • TPH $46.91
  • IMVT $32.10
  • Technical
  • Relative Strength Index (RSI)
  • TPH 35.46
  • IMVT 51.86
  • Support Level
  • TPH $33.65
  • IMVT $15.95
  • Resistance Level
  • TPH $34.96
  • IMVT $17.15
  • Average True Range (ATR)
  • TPH 0.79
  • IMVT 0.72
  • MACD
  • TPH -0.20
  • IMVT 0.07
  • Stochastic Oscillator
  • TPH 3.53
  • IMVT 62.65

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: